Also known as: LSEG
LSEG (London Stock Exchange Group) is a global financial markets infrastructure and data provider. It operates trading venues, post-trade services, and financial data businesses.
Deutsche Bank upgraded Merck to Buy and raised its price target to $150 from $115, citing a clear path beyond Keytruda’s patent expiration. Merck meanwhile forecast 2026 revenue of $65.5 billion to $67.0 billion and said it faces a $2.5 billion headwind this year.
Charles River Laboratories forecasts 2026 adjusted earnings of $10.70-$11.20 per share, exceeding Wall Street expectations, as biotech demand for drug research services recovers and contract cancellations decline.
Charles River Laboratories forecast 2026 adjusted profit of $10.70 to $11.20 per share, above Wall Street estimates, citing improved demand for drug discovery and development services from biotech clients.
